| Date Filed | Type | Description |
| 04/06/2023 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 02/14/2023 |
SC 13G/A
| Whitefort Capital Master Fund, LP reports a 0% stake in Renren Inc. |
| 02/14/2023 |
SC 13G/A
| Whitefort Capital Master Fund, LP reports a 1% stake in SRAX, Inc. |
| 04/06/2022 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 02/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/23/2021 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 6.1% stake in Renren Inc. |
| 04/06/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Whitefort Capital Master Fund, LP reports a 0% stake in SciPlay Corporation |
| 04/06/2020 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 03/20/2020 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 5.4% stake in SciPlay Corporation |
| 03/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Whitefort Capital Master Fund, LP reports a 0% stake in MTech Acquisition Corp. |
| 09/27/2019 |
SC 13D/A
| Whitefort Capital Master Fund, LP reports a 1.5% stake in Novelion Therapeutics Inc. |
| 07/01/2019 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 5.4% stake in NII Holdings, Inc. |
| 06/20/2019 |
SC 13D/A
| Whitefort Capital Master Fund, LP reports a 9.9% stake in Novelion Therapeutics Inc. |
| 05/24/2019 |
SC 13D/A
| Whitefort Capital Master Fund, LP reports a 9.9% stake in Novelion Therapeutics Inc. |
| 05/03/2019 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 5.7% stake in Trinity Biotech plc |
| 04/05/2019 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 04/02/2019 |
SC 13D/A
| Whitefort Capital Master Fund, LP reports a 8.3% stake in Novelion Therapeutics Inc. |
| 03/29/2019 |
SC 13D
| Whitefort Capital Master Fund, LP reports a 8.3% stake in Novelion Therapeutics Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/26/2018 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 6% stake in MTech Acquisition Corp. |
| 08/23/2018 |
SC 13G
| Whitefort Capital Master Fund, LP reports a 5.5% stake in Novelion Therapeutics Inc. |
| 04/05/2018 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 04/20/2017 |
D
| Form D - Notice of Exempt Offering of Securities |